Focused on cancer metabolism, the study of the altered metabolism of cancer cells.

Develops cancer therapies for the treatment of cancer patients with bone metastases.

Specializing in scientifically validated drug development in treatment of cancer with niche indications.

Discovering, developing and commercializing targeted therapies for anti cancer drugs.

Provides research, development and technology to discover drugs that address unmet needs in diseases such as cancer and inflammation.

Developing therapeutic agents, diagnostics, and lifestyle recommendations that make possible the treatment of risk factors for cancer.

A clinical stage biotechnology company developing drugs to treat hypoxia.

Working to transform the way cancer is treated, with the goal of moving cancer therapy research towards a more manageable disease.

Provides vaccine and drug developers with a clinically relevant system for delivering nucleic acids safely and intact to the interior of the target cell.

Developing DNA vaccine technology focused on extending the benefits of vaccines by preventing and treating cancers and infectious diseases.

Developing galectins to develop innovative new therapies to treat human diseases such as cancer and chronic organ failure.

Developing medicines to fight cancer with signal transduction inhibition, cytotoxic agents, antiangiogenesis, cell cyle/apoptosis, iron chelation, metastases and hormone therapy.

Developing monoclonal antibodies and other agents that target the biologic pathways critical to tumor initiating cells.

Develops compounds for oncology that act by restoration of the activity of the protein phosphatase 2A (PP2A) tumor suppressor.

Specializing in the development and commercialization of innovative cancer therapies.

Engaged in the development of a platform technology and proprietary products for the treatment of cancer.

Develops and commercializes products for the treatment of opioid induced constipation, prostate cancer, human immunodeficiency virus and Hepatitis C virus.

Developing advanced therapies designed to target and destroy the deadliest cancers, melanoma, liver and breast, while eliminating side effects.

Specializes in the development, manufacturing and delivery of products focused in in vitro diagnostic tests for the screening, monitoring and detection of more than 15 different types of cancer.

Developing and delivering cures for cancer and disorders of the central nervous system.

Works to bridge the gap between the molecular mechanisms of cancer and clinical practice.

Specializing in the development and commercialization of small molecule and synthetic biology approaches to new cancer therapies.